CAS No.982-57-0,Butanedioic acid,1-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl]ester, sodium salt (1:1) Suppliers

Detail of "982-57-0"

CAS Number:

982-57-0

Name:

Butanedioic acid,1-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl]ester, sodium salt (1:1)

Superlist Name:

Chloramphenicol sodium succinate

Molecular Structure:

Formula:

C₁₅H₁₆Cl₂N₂O₈.Na

Molecular Weight:

445.18

Synonyms:

Butanedioicacid, mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl]ester, monosodium salt (9CI);Butanedioic acid,mono[2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester,monosodium salt, [R-(R*,R*)]-;Succinic acid, a-monoester with D-threo-(-)-2,2-dichloro-N-[b-hydroxy-a-(hydroxymethyl)-p-nitrophenethyl]acetamide,monosodium salt (8CI);Betamicetin;Chloramphenicol monosuccinate sodium salt;Chloramphenicol succinate sodium;Clorofenicina;Cloromoin;Levomycetin-Nalcein;Mychel-S;Nalecin;Nevimycin;Protophenicol;Sodium chloramphenical monosuccinate;Solnicol;

EINECS:

213-568-1

Solubility:

Freely soluble in water

Appearance:

White powder

Hazard Symbols:

Risk Codes:

Safety:

22-36 Details

Reference

Experimental studies on inner ear damage in guinea pigs caused by intratympanic injection of chloramphenicol sodium succinate: Experimental studies on inner ear damage in guinea pigs caused by intratympanic injection of chloramphenicol sodium succinate. Hashimoto, Masao (Sch. Med., Iwate Med. Sch., Morioka, Japan). Iwate Igaku Zasshi, 29(1), 120-9 (Japanese) 1977. CODEN: IIZAAX. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) The inner ear damage in guinea pigs caused by intratympanic injection of chloramphenicol Na succinate (I Na succinate) [982-57-0] was due to the pharmacol. effect of I not the osmotic pressure of the prepn.

Effect of drugs on erythrocytes: Effect of drugs on erythrocytes. I. Influence of pH, osmotic pressure and a few drugs on erythrocyte destruction. Horioka, Masayoshi; Aoyama, Toshinobu; Yokoyama, Ikuko; Hatta, Yumiko (Fac. Med., Kyushu Univ., Fukuoka, Japan). Chem. Pharm. Bull., 25(8), 2098-104 (English) 1977. CODEN: CPBTAL. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) Removal of ascorbic acid [50-81-7] from tetracycline-HCl [64-75-5] prepns. prevented destruction of erythrocytes and chloramphenicol sodium succinate [982-57-0] did not disrupt erythrocytes even in a high concn. These results indicated that erythrocyte destruction by parenteral soln. was possibly due to the pH and osmotic pressure of the drug soln. and to additives rather than, or in addn. to, the direct action of drugs. Reexamn. of the test methods for hemolysis and establishment of judgment stds. are desirable.

Detail of "982-57-0"

Butanedioic acid,1-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl]ester, sodium salt (1:1)

Famous Chemical Enterprises

Related products

Other Products

Supplier Location

Business Type

Certificates

Exhibitions

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

CAS No.982-57-0 Chloramphenicol sodium succinate

Reference